Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Non-invasive multi-cancer detection using DNA hypomethylation of LINE-1 retrotransposons.
Michel M, Heidary M, Mechri A, Da Silva K, Gorse M, Dixon V, von Grafenstein K, Bianchi C, Hego C, Rampanou A, Lamy C, Kamal M, Le Tourneau C, Séné M, Bieche I, Reyes C, Gentien D, Stern MH, Lantz O, Cabel L, Pierga JY, Bidard FC, Azencott CA, Proudhon C. Michel M, et al. Among authors: pierga jy. Clin Cancer Res. 2024 Dec 2. doi: 10.1158/1078-0432.CCR-24-2669. Online ahead of print. Clin Cancer Res. 2024. PMID: 39620930
[Triple negative breast cancer: Current status and perspectives].
Le Du F, Moati E, Vaflard P, Bailleux C, Pierga JY, Dieras V. Le Du F, et al. Among authors: pierga jy. Bull Cancer. 2024 Nov 6:S0007-4551(24)00336-9. doi: 10.1016/j.bulcan.2024.09.002. Online ahead of print. Bull Cancer. 2024. PMID: 39510910 Review. French.
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.
Bardia A, Hu X, Dent R, Yonemori K, Barrios CH, O'Shaughnessy JA, Wildiers H, Pierga JY, Zhang Q, Saura C, Biganzoli L, Sohn J, Im SA, Lévy C, Jacot W, Begbie N, Ke J, Patel G, Curigliano G; DESTINY-Breast06 Trial Investigators. Bardia A, et al. Among authors: pierga jy. N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMoa2407086. Online ahead of print. N Engl J Med. 2024. PMID: 39282896
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study.
Jhaveri KL, Lim E, Jeselsohn R, Ma CX, Hamilton EP, Osborne C, Bhave M, Kaufman PA, Beck JT, Manso Sanchez L, Parajuli R, Wang HC, Tao JJ, Im SA, Harnden K, Yonemori K, Dhakal A, Neven P, Aftimos P, Pierga JY, Lu YS, Larson T, Jerez Y, Sideras K, Sohn J, Kim SB, Saura C, Bardia A, Sammons SL, Bacchion F, Li Y, Yuen E, Estrem ST, Rodrik-Outmezguine V, Nguyen B, Ismail-Khan R, Smyth L, Beeram M. Jhaveri KL, et al. Among authors: pierga jy. J Clin Oncol. 2024 Sep 6:JCO2302733. doi: 10.1200/JCO.23.02733. Online ahead of print. J Clin Oncol. 2024. PMID: 39241211
Deformation under flow and morphological recovery of cancer cells.
Gasser E, Su E, Vaidžiulytė K, Abbade N, Cognart H, Manneville JB, Viovy JL, Piel M, Pierga JY, Terao K, Villard C. Gasser E, et al. Among authors: pierga jy. Lab Chip. 2024 Aug 6;24(16):3930-3944. doi: 10.1039/d4lc00246f. Lab Chip. 2024. PMID: 38993177 Free PMC article.
368 results